Generation of a C57BL/6J mouse strain expressing the CD45.1 epitope to improve hematopoietic stem cell engraftment and adoptive cell transfer experiments.
Journal
Lab animal
ISSN: 1548-4475
Titre abrégé: Lab Anim (NY)
Pays: United States
ID NLM: 0417737
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
15
06
2023
accepted:
05
10
2023
medline:
4
12
2023
pubmed:
29
11
2023
entrez:
28
11
2023
Statut:
ppublish
Résumé
Adoptive cell transfer between genetically identical hosts relies on the use of a congenic marker to distinguish the donor cells from the host cells. CD45, a glycoprotein expressed by all hematopoietic cells, is one of the main congenic markers used because its two isoforms, CD45.1 and CD45.2, can be discriminated by flow cytometry. As a consequence, C57BL/6J (B6; CD45.2) and B6.SJL-Ptprc
Identifiants
pubmed: 38017180
doi: 10.1038/s41684-023-01275-1
pii: 10.1038/s41684-023-01275-1
doi:
Substances chimiques
Epitopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-331Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Shen, F. W. et al. Cloning of Ly-5 cDNA. Proc. Natl Acad. Sci. USA 82, 7360–7363 (1985).
doi: 10.1073/pnas.82.21.7360
pmcid: 391344
pubmed: 3864163
Waterstrat, A., Liang, Y., Swiderski, C. F., Shelton, B. J. & Van Zant, G. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood 115, 408–417 (2010).
doi: 10.1182/blood-2008-03-143370
pmcid: 2808161
pubmed: 19901263
Chisolm, D. A. et al. Defining genetic variation in widely used congenic and backcrossed mouse models reveals varied regulation of genes important for immune responses. Immunity 51, 155–168.e5 (2019).
doi: 10.1016/j.immuni.2019.05.006
pmcid: 6883924
pubmed: 31248780
Basu, S., Ray, A. & Dittel, B. N. Differential representation of B cell subsets in mixed bone marrow chimera mice due to expression of allelic variants of CD45 (CD45.1/CD45.2). J. Immunol. Methods 396, 163–167 (2013).
doi: 10.1016/j.jim.2013.07.008
pubmed: 23928494
Mercier, F. E., Sykes, D. B. & Scadden, D. T. Single targeted exon mutation creates a true congenic mouse for competitive hematopoietic stem cell transplantation: the C57BL/6-CD45.1 STEM mouse. Stem Cell Rep. 6, 985–992 (2016).
doi: 10.1016/j.stemcr.2016.04.010
Jafri, S., Moore, S. D., Morrell, N. W. & Ormiston, M. L. A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model. Sci. Rep. 7, 3495 (2017).
doi: 10.1038/s41598-017-03784-9
pmcid: 5471196
pubmed: 28615666
Jang, Y. et al. Cutting edge: check your mice—a point mutation in the Ncr1 locus identified in CD45.1 congenic mice with consequences in mouse susceptibility to infection. J. Immunol. 200, 1982–1987 (2018).
doi: 10.4049/jimmunol.1701676
pubmed: 29440507
Gray, E. E. et al. Deficiency in IL-17-committed Vγ4
doi: 10.1038/ni.2585
pmcid: 3660499
pubmed: 23624556
Tulone, C., Tsang, J., Prokopowicz, Z., Grosvenor, N. & Chain, B. Natural cathepsin E deficiency in the immune system of C57BL/6J mice. Immunogenetics 59, 927–935 (2007).
doi: 10.1007/s00251-007-0256-0
pubmed: 18000662
Grau, M. et al. Antigen-induced but not innate memory CD8 T cells express NKG2D and are recruited to the lung parenchyma upon viral infection. J. Immunol. 200, 3635–3646 (2018).
doi: 10.4049/jimmunol.1701698
pubmed: 29632146
Zebedee, S. L., Barritt, D. S. & Raschke, W. C. Comparison of mouse Ly5a. and Ly5b leucocyte common antigen alleles. Dev. Immunol. 12, 243–254 (1991).
doi: 10.1155/1991/52686
Kornete, M., Marone, R. & Jeker, L. T. Highly efficient and versatile plasmid-based gene editing in primary T cells. J. Immunol. 200, 2489–2501 (2018).
doi: 10.4049/jimmunol.1701121
pmcid: 5857648
pubmed: 29445007
Concordet, J.-P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242–W245 (2018).
doi: 10.1093/nar/gky354
pmcid: 6030908
pubmed: 29762716
Chain, B. M. et al. The expression and function of cathepsin E in dendritic cells. J. Immunol. 174, 1791–1800 (2005).
doi: 10.4049/jimmunol.174.4.1791
pubmed: 15699105
Kakehashi, H. et al. Differential regulation of the nature and functions of dendritic cells and macrophages by cathepsin E. J. Immunol. 179, 5728–5737 (2007).
doi: 10.4049/jimmunol.179.9.5728
pubmed: 17947645
Pilzner, C. et al. Allergic airway inflammation in mice deficient for the antigen-processing protease cathepsin E. Int. Arch. Allergy Immunol. 159, 367–383 (2012).
doi: 10.1159/000338288
pubmed: 22846634
Teixeira, M. et al. Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing. Sci. Rep. 8, 474 (2018).
doi: 10.1038/s41598-017-18826-5
pmcid: 5764989
pubmed: 29323173
Simon, M. M. et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 14, R82 (2013).
doi: 10.1186/gb-2013-14-7-r82
pmcid: 4053787
pubmed: 23902802
Hiramatsu, S. Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4
doi: 10.1038/s41598-019-38809-y
pubmed: 30816218
Tsukuba, T. Association of cathepsin E deficiency with development of atopic dermatitis. J. Biochem. 134, 893–902 (2003).
doi: 10.1093/jb/mvg216
pubmed: 14769879
Mengwasser, J. et al. Cathepsin E deficiency ameliorates graft-versus-host disease and modifies dendritic cell motility. Front. Immunol. 8, 203 (2017).
doi: 10.3389/fimmu.2017.00203
pmcid: 5331043
pubmed: 28298913
Jubin, V. et al. T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production. Immunol. Res. 52, 284–293 (2012).
doi: 10.1007/s12026-012-8340-4
pubmed: 22528127
Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533, 125–129 (2016).
doi: 10.1038/nature17664
pubmed: 27120160
Hendel, A. et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat. Biotechnol. 33, 985–989 (2015).
doi: 10.1038/nbt.3290
pmcid: 4729442
pubmed: 26121415
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR–Cas9 using asymmetric donor DNA. Nat. Biotechnol. 34, 339–344 (2016).
doi: 10.1038/nbt.3481
pubmed: 26789497
Renaud, J.-B. et al. Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR–Cas9 nucleases. Cell Rep. 14, 2263–2272 (2016).
doi: 10.1016/j.celrep.2016.02.018
pubmed: 26923600
Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013).
doi: 10.1038/nbt.2647
pmcid: 3969858
pubmed: 23873081
Brinza, L. et al. Immune signatures of protective spleen memory CD8 T cells. Sci. Rep. 6, 37651 (2016).
doi: 10.1038/srep37651
pmcid: 5121635
pubmed: 27883012